New York State Common Retirement Fund’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $98K | Sell |
10,414
-9,700
| -48% | -$91.3K | ﹤0.01% | 2673 |
|
2025
Q1 | $109K | Buy |
20,114
+13,600
| +209% | +$73.7K | ﹤0.01% | 2473 |
|
2024
Q4 | $49K | Hold |
6,514
| – | – | ﹤0.01% | 2858 |
|
2024
Q3 | $52K | Sell |
6,514
-181,807
| -97% | -$1.45M | ﹤0.01% | 2854 |
|
2024
Q2 | $1.64M | Sell |
188,321
-10,439
| -5% | -$90.8K | ﹤0.01% | 1542 |
|
2024
Q1 | $4.11M | Buy |
198,760
+177,249
| +824% | +$3.66M | 0.01% | 1194 |
|
2023
Q4 | $497K | Buy |
21,511
+13,735
| +177% | +$317K | ﹤0.01% | 2094 |
|
2023
Q3 | $62K | Sell |
7,776
-7,906
| -50% | -$63K | ﹤0.01% | 2939 |
|
2023
Q2 | $136K | Sell |
15,682
-52
| -0.3% | -$451 | ﹤0.01% | 2662 |
|
2023
Q1 | $46K | Hold |
15,734
| – | – | ﹤0.01% | 3002 |
|
2022
Q4 | $55K | Buy |
15,734
+4
| +0% | +$14 | ﹤0.01% | 3075 |
|
2022
Q3 | $124K | Buy |
15,730
+8,558
| +119% | +$67.5K | ﹤0.01% | 2947 |
|
2022
Q2 | $56K | Sell |
7,172
-5,418
| -43% | -$42.3K | ﹤0.01% | 3212 |
|
2022
Q1 | $153K | Buy |
12,590
+43
| +0.3% | +$523 | ﹤0.01% | 2904 |
|
2021
Q4 | $154K | Sell |
12,547
-55
| -0.4% | -$675 | ﹤0.01% | 2961 |
|
2021
Q3 | $131K | Sell |
12,602
-5,498
| -30% | -$57.2K | ﹤0.01% | 3052 |
|
2021
Q2 | $163K | Buy |
+18,100
| New | +$163K | ﹤0.01% | 3110 |
|
2020
Q2 | – | Sell |
-3,290
| Closed | -$34K | – | 3236 |
|
2020
Q1 | $34K | Hold |
3,290
| – | – | ﹤0.01% | 3050 |
|
2019
Q4 | $51K | Sell |
3,290
-3,080
| -48% | -$47.7K | ﹤0.01% | 3125 |
|
2019
Q3 | $115K | Hold |
6,370
| – | – | ﹤0.01% | 2989 |
|
2019
Q2 | $104K | Buy |
+6,370
| New | +$104K | ﹤0.01% | 3088 |
|